Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy

Nature

Volumn 418, Issue 6896, 2002, Pages 422-425

  Moore, Steeven A ^a   Saito, Fumiaki ^a   Chen, Jianguo ^a   Michele, Daniel E ^a   Henry, Michael D ^a   Messing, Albee ^b   Cohn, Ronald D ^a   Ross Barta, Susan E ^a   Westra, Steve ^a   Williamson, Roger A ^a   Hosl, Toshinori ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; MUSCLE; MUTAGENESIS; PATIENT MONITORING;

MUSCLE-EYE-BRAIN DISEASE (MEB);

BRAIN;

MEDICINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GENE DELETION; GENE FUNCTION; LONG TERM POTENTIATION; MOUSE; MUSCULAR DYSTROPHY; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

ANIMALS; BRAIN; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; ELECTROPHYSIOLOGY; GENE DELETION; GLYCOSYLATION; HIPPOCAMPUS; LAMININ; LEARNING; LONG-TERM POTENTIATION; MEMBRANE GLYCOPROTEINS; MEMORY; MICE; MICE, KNOCKOUT; MUSCULAR DYSTROPHIES; NEURONS; ORGAN SPECIFICITY; SYNDROME;

ANIMALIA;

EID: 0037173629     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature00838     Document Type: Article

References (30)

1. Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations
2. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
3. Clinical and genetic distinction between Walker-Warburg syndrome and muscleeye-brain disease
4. Muscle-eye-brain disease: A neuropathological study
5. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1
6. Dystroglycan inside and out
7. Dystroglycandistribution in adult mouse brain: A light and electron microscopy study
8. The molecular basis of muscular dystrophy
9. A stoichiometric complex of neurexins and dystroglycan in brain
10. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
11. Role of the basement membrane in neurogenesis and repair of injury in the central nervous system
12. Perlecan is essential for cartilage and cephalic development
13. Synergistic activities of α3 and α6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse
14. Roles for laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking the laminin α5 chain
15. β1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex
16. Human brain malformations and their lessons for neuronal migration
17. The fukutin protein family-predicted enzymes modifying cell-surface molecules
18. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse
19. Mutations in the Fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan
20. Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy
21. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies
22. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
23. Maturation and maintenance of the neuromuscular synapse: Genetic evidence for roles of the dystrophin-glycoprotein complex
24. A synaptic model of memory: Long-term potentiation in the hippocampus
25. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation
26. Glia: Listening and talking to the synapse
27. Fetal and adult hematopoietic stem cells require β1 integrin function for colonizing fetal liver, spleen, and bone marrow
28. Progressive muscular dystrophy in α-sarcoglycan-deficient mice
29. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
30. Postsynaptic factors control the duration of synaptic enhancement in area CA1 of the hippocampus